PATENT CLAIM ANALYSIS

Application Number: 15996162
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-04
Patent Classification: ["514", "275000"]

Abstract:
The present invention provides compounds, pharmaceutically acceptable compositions thereof, and methods of using the same.

Claim (Index 91):
The method according to  claim 90 , wherein the BTK-mediated disorder is selected from rheumatoid arthritis, multiple sclerosis, B-cell chronic lymphocytic leukemia, acute lymphocytic leukemia, hairy cell leukemia, non-Hodgkin's lymphoma, Hodgkin's lymphoma, multiple myeloma, bone cancer, bone metastasis, osteoporosis, irritable bowel syndrome, Crohn's disease, lupus, or disorders associated with renal transplant.

Metadata:
- Claim Count in Document: 65.0
- Percentile: 94.0
- Lexical Diversity: 1.05882
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13670937', '13671129', '15080351', '12492180', '14296376']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.9086001282007542
- 35 USC 102 Novelty (BERT): 0.5876838866225057
- Combined Prediction Score: 0.8765085040429293
- Mean Citation Score: 656.062982
- Max Citation Score: 695.6846
- Similarity Product: 369.9164111834765

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test